FDA Inspection 856475 — Cooper Health System IRB

Cooper Health System IRB — FEI 2243630

The FDA completed an inspection of Cooper Health System IRB on Dec 3, 2013 in Camden, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Dec 3, 2013
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Camden, NJ (United States)

Additional details

IRB

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.